GUARDANT HEALTH INC.
ASSOCIATION FOR MOLECULAR PATHOLOGY
ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION
TWIST BIOSCIENCE CORPORATION
MW
At a glance
Works on
The past 12 months
Clients
4
past 12 months
Filings
4
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)Food & Drug Administration (FDA)Natl Institutes of Health (NIH)
Specific issues
HR 2036 HEALTHY BRAINS Act NOT-OD-26-047: Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Fiscal Years 2027-2031
HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)
Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards for Prior Authorization (CMS-0068-P)
S.3741 - Biosecurity Modernization and Innovation Act of 2026
H.R. 8890: Enhancing CLIA Act of 2026
H.R.3152/S.1546: Patent Eligibility Restoration Act
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗